What are the major features of NeuroShield that make it one of a kind in India?
NeuroShield is the first such product to be using AI in brain volumetry outside of the US and EU and the first in India. It is also the first to use an ethnicity/ geography-based reference range. One of the reasons the other products were not adopted here in India was because the reference data was not relevant but this approach of ethnicity-based reference is a new approach to using data analytics relevant for different populations. Finally, our cost structure makes it affordable and accessible to all. We spent close to 18 months in the actual development of this product and another year was put in for preparation and research. The company was formed in Jan 2018 and the product was launched in Jan 2020.
What is your current reach and how do you plan to further enhance it?
Right now, we have partnered with over 15 hospitals in major and minor cities. Some of these hospitals like Max Neuro are a chain hospital with 14 hospitals and similarly, Aarthi Scans has over 25 centers. To name a few more, we are associated with hospitals and screening centres such as Sahyadri Hospital, Deenanath Mangeshkar Hospital, NM Medical, P.H diagnostic centre and Noble Hospital. To fulfill our social mission, we also plan to expand our presence in Tier 2 and Tier 3 cities. We also plan to expand our global footprint. We are in talks with hospitals in Dubai, Philippines, Indonesia and Australia. We are also in touch with Abu Dhabi government agency about opening an office in their innovation center.
How do you intend to contribute to mental healthcare in India?
Denne historien er fra March 2020-utgaven av BioSpectrum Asia.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra March 2020-utgaven av BioSpectrum Asia.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.
Singapore designs novel gene therapy offering hope for epilepsy patients
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.
Spider venom heart drug moves to clinical trials in Australia
A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).
India develops portable ultrasound scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.
Integris appoints medtech veteran Probir Das as new CEO
Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.
Clarity Pharma promotes Michelle Parker to CEO
Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.